Here's the Major Earnings Before the Open Tomorrow
Plaintiff Sues Eli Lilly, Johnson & Johnson Over Alleged Breast Cancer Risk Linked To Antipsychotic Medications
AbbVie Immunology Portfolio Poised For Growth Through Humira Erosion: Analyst
Puma Biotechnology Presents Clinical Data Of Phase I Trial Of Trastuzumab Deruxtecan In Combination With Neratinib In Solid Tumors With HER2 Alterations At AACR 2025
AbbVie's Options Frenzy: What You Need to Know
SA Analyst Downgrades: TSLA, AAPL, T, PG, HPE, GILD, LRCX, ARCC